Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Biotec Pharmacon ASA

Closing information (x1000 DKK)

Closing information 2019/12 (consolidated) 2018/12 (consolidated) 2017/12 (consolidated)
Turnover 63,918 Less Arrow 54,215 More Arrow 55,047
Financial expenses 614 Less Arrow 0 More Arrow 526
Earnings before taxes -4,488 Less Arrow -10,295 Less Arrow -18,765
Total assets 58,778 Less Arrow 50,639 Less Arrow 46,668
Current assets 44,374 Less Arrow 41,595 Less Arrow 37,804
Current liabilities 13,911 Less Arrow 10,511 More Arrow 12,763
Equity capital 35,199 More Arrow 40,129 Less Arrow 33,904
- share capital 36,607 Less Arrow 35,987 Less Arrow 33,248
Employees (average) 38 More Arrow 43 More Arrow 44
Shareholders 0 0 0

Financial ratios

Fiscal year 2019/12 (consolidated) 2018/12 (consolidated) 2017/12 (consolidated)
Solvency 59.9% More Arrow 79.2% Less Arrow 72.6%
Turnover per employee 1,682 Less Arrow 1,261 Less Arrow 1,251
Profit as a percentage of turnover -7.0% Less Arrow -19.0% Less Arrow -34.1%
Return on assets (ROA) -6.6% Less Arrow -20.3% Less Arrow -39.1%
Current ratio 319.0% More Arrow 395.7% Less Arrow 296.2%
Return on equity (ROE) -12.8% Less Arrow -25.7% Less Arrow -55.3%
Change turnover 8,769 Less Arrow 44 Less Arrow -4,424
Change turnover % 16% Less Arrow 0% Less Arrow -7%
Chg. No. of employees -5 More Arrow -1 Less Arrow -2
Chg. No. of employees % -12% More Arrow -2% Less Arrow -4%

Total value of public sale

Fiscal year 2019/12 (consolidated) 2018/12 (consolidated) 2017/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.